WRM
VRTX icon

Westport Resources Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Westport Resources Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-72
Closed -$5K – 1116
2014
Q1 		$5K Hold
72
– – ﹤0.01% 990
2013
Q4 		$5K Hold
72
– – ﹤0.01% 1030
2013
Q3 		$5K Hold
72
– – ﹤0.01% 1002
2013
Q2 		$6K Buy
+72
New +$5.3K ﹤0.01% 955

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Westport Resources Management's VRTX Position: Q2 2014 in Review

Westport Resources Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2014, closing a stake of 72 shares — an estimated $5K sold.

Westport Resources Management first reported a position in VRTX in Q2 2013 and held it in 4 quarters. The position peaked at $6K in Q2 2013. 411 funds tracked by Wall St. Rank hold VRTX as of Q2 2014.

  • Westport Resources Management reported no remaining Vertex Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Westport Resources Management sold 72 Vertex Pharmaceuticals shares in Q2 2014, an estimated $5K.
  • Westport Resources Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Westport Resources Management's Vertex Pharmaceuticals position peaked at $6K in Q2 2013.
  • 411 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2014.

Based on Westport Resources Management's 13F filing for Q2 2014, filed 31 Jul 2014.